Neuroinflammation, caused by 6 days of intracerebroventricular infusion of a low dose of lipopolysaccharide (LPS, 0.5 ng/h), stimulates brain arachidonic acid (AA) metabolism in rats, but 6 weeks of lithium pretreatment reduces this effect. To further understand this action of lithium, we measured concentrations of eicosanoids and docosanoids generated from AA and docosahexaenoic acid (DHA), respectively, in high-energy microwaved rat brain, using liquid chromatography-tandem mass spectrometry and two doses of LPS. In rats fed a lithium-free diet, low (0.5 ng/h) or high (250 ng/h) dose LPS compared to artificial cerebrospinal fluid increased brain unesterified AA and prostaglandin E 2 concentrations, and activities of AA-selective cytosolic cPLA 2 -IV and secretory sPLA 2 .
(resolution phase interaction products) and docosatrienes were introduced because they displayed potent anti-inflammatory and immunoregulatory properties. The enzymatic conversion of DHA to docosanoids has not been fully characterized, but appears to involve an initial conversion of DHA to 17S-hydroxy-DHA (17-OH-DHA) by a 15-lipoxygenase (15-LOX)-like enzyme and further conversion to resolvins D via epoxide intermediates (13). So far, only isolated soybean and potato15-LOX and porcine have been shown to convert DHA to 17-OH-DHA in vitro (10, 14, 15) .
Lithium has been used to treat bipolar disorder for over 50 years, and remains the most common treatment for its manic phase (16, 17) . While lithium's mechanism of action is not agreed on, recent animal studies suggest that lithium downregulates the brain AA cascade by decreasing AA turnover within brain phospholipids (18) and the prostaglandin E 2 (PGE 2 ) concentration (19) . To study effects of lithium on the brain AA and DHA cascades during neuroinflammation, we used an animal model of neuroinflammation. In rats, neuroinflammation can be produced by chronic infusion of bacterial lipopolysaccharide (LPS) into the fourth cerebral ventricle (20) . A 6-day infusion of high dose LPS (250 ng/h) increases activated microglia in the thalamus (21) .
A lower LPS dose (0.5 or 1 ng/h) infused for 6 or 30 days produces behavioral deficits, induces amyloid deposits, and activates microglia and astrocytes (22, 23). We reported that a 6-day infusion of the low dose also increases markers of the brain AA metabolic rats for 6 weeks, so as to produce plasma and brain lithium concentrations therapeutically relevant to bipolar disorder, prevented many of these LPS-induced increments (24). The LPS infusion did not change the brain unesterified DHA concentration (22), DHA turnover in brain phospholipids (Rosenberger T.A. and Rapoport, S. I., unpublished observations), or activity of Ca 2+ -independent iPLA 2 , which is selective for DHA (22, 25).
Reverse phase-HPLC coupled with mass spectrometry (RP-HPLC/MS/MS) has emerged as one of the most specific and sensitive approaches used in the analysis of lipid mediators in biological samples (26). This method has been validated for quantifying concentrations of unesterified fatty acids and their metabolites in rodent brains that have been subjected to high-energy head-focused microwaving to stop lipid metabolism and limit postmortem alterations (27, 28) . Others and we have demonstrated that such radiation is essential for measuring accurate brain concentrations of unesterified fatty acids, eicosanoids and anandamide (29). Indeed, during global ischemia caused by decapitation, concentrations of unesterified fatty acids are rapidly increased (27, 28, 30).
The goal of this study was to further investigate the interaction between chronic lithium and neuroinflammation, by measuring concentrations of unesterified polyunsaturated fatty acids and some of their metabolites in high-energy microwaved brain of rats fed LiCl chronically, using RP-HPLC/MS/MS as described in our ischemia study (27 LiCl-fed rats infused with LPS, suggesting a new beneficial mechanism of action of lithium in bipolar disorder as an anti-inflammatory agent.
Materials and methods

Animals
All procedures were performed under a protocol (#06-026) approved by the Animal Care 
Total fatty acid concentrations in control and LiCl diets
To analyze each diet, total lipids were extracted (32) from 0.7-0.8 g samples. An aliquot of total lipid extract was methylated with 1% H 2 SO 4 -methanol for 3 h at 70°C. Fatty acid methyl esters were then separated and quantified by gas-liquid chromatography. Before the sample was methylated, di-17:0 choline glycerophospholipid was added as an internal standard.
Surgery
Rats were anesthetized and an indwelling cerebroventricular cannula was fixed in place as previously described (20, 22, 24 
Western blot analysis
Proteins (50 µg) from the cytosolic fractions were separated on 4-20% SDS-PAGE (BioRad, Hercules, CA), blotted onto a polyvinylidene difluoride membrane (Bio-Rad), and then immunoblotted with the goat anti-15-LOX-2 polyclonal antibody (1:1000) (Santa Cruz, Santa Cruz, CA). Blotted proteins were quantified using Alpha Innotech Software (Alpha Innotech, San Leandro, CA) and were normalized to β-actin (Sigma).
Statistical analysis
A two-way ANOVA, comparing diet (LiCl vs. control) with infusion (LPS vs. aCSF) was (Table 1) The fatty acid concentrations (µmol/g diet) in the three diets are shown in Table 1 . There was no significant difference between the three diets in fatty acid composition. The analysis showed that the 5001 diet contained (as percent of total fatty acids): 25.2% saturated, 33.3% monounsaturated, 35.1% linoleic, 3.1% α-linolenic, 0.39% AA, 1.25% eicosapentaenoic and 1.62% docosahexaenoic acid.
Results
Fatty acid composition of diets
Effect of cannula implantation
Initial experiments investigated the effects, if any, of implanting the cannula and infusing aCSF on brain concentrations of unesterified fatty acids, eicosanoids and 17-OH-DHA.
Except for PGE 2 , the concentration of none of these substances was altered by the cannula implant plus aCSF infusion (data not shown). A very low concentration of PGE 2
(at the limit of detection) was detected in 1 of 4 brains of control diet and in 1 of 4 brains of lithium diet rats infused with aCSF. These findings show a slight occasional effect of cannula implantation, likely due to minimal neuroinflammation around the cannula track (35), whereas in a prior study PGE 2 could not be detected in control microwaved rat brain in the absence of a cannula (27). Low dose LPS-or aCSF-infused rats with indwelling catheters appeared behaviorally normal after 24 h, whereas high dose LPS-infused rats were lethargic and docile throughout the 6-day infusion period.
Weight and other effects
A two-way ANOVA showed a significant main effect of LPS infusion (p < 0.0001) but no significant main effect of diet (p = 0.67) or diet x LPS interaction (p = 0.32) with regard to body weight (data not shown). A Bonferroni post-hoc test indicated that high dose LPS significantly decreased body weight in both groups by 20% (p < 0.001) whereas low dose LPS had a significant effect (7% reduction) only in the control diet rats.
Unesterified fatty acids
Brain concentrations of unesterified AA, DHA and DPA are summarized in Table 2 . A two-way ANOVA showed a significant diet x LPS interaction for the AA concentration A low concentration of PGE 2 at the limit of detection was detected in 1 of 4 brains from control and lithium diet rats infused with aCSF. Higher concentrations were found in control diet rats infused with LPS (Table 2) . A two-way ANOVA showed a significant diet x LPS interaction for the PGE 2 concentration (p < 0.001). Subsequent one-way
ANOVAs with Bonferroni post-hoc tests showed that high dose LPS significantly increased brain PGE 2 by 18.5-fold, and that the LiCl diet prevented this increase ( Table   2 ). The TXB 2 concentration is not reported since it was below the limit of detection in each sample.
Treatment effects on concentrations of 5-HETE, 5-oxo-ETE, 12-HETE and 15-HETE also are summarized in Table 2 Table 2 ). The interaction between
LiCl and LPS was insignificant, and LPS had no main effect.
PLA 2 activities and 15-LOX protein
A two-way ANOVA on whole brain cPLA 2 -IV and sPLA 2 specific activities showed significant diet x LPS interactions, at p = 0.0002 and p < 0.0001, respectively (Table 3) .
Subsequent one-way ANOVAs with Bonferroni post-hoc tests showed that both doses of LPS compared with aCSF significantly increased brain cPLA 2 -IV activity by 36% and 148%, respectively, and brain sPLA 2 activity by 41% and 80%, respectively. The LiCl diet prevented the significant increment of cPLA 2 -IV activity following low but not high dose LPS, as well as the significant increments in sPLA 2 activity caused by low and high dose LPS. Neither the LiCl diet nor LPS infusion significantly affected whole brain iPLA 2 -VI activity.
Brain cytosolic 15-LOX protein levels were not significantly altered by LPS infusion in LiCl-treated rats (n = 4, p > 0.05) (data not shown).
Discussion
The major new finding of our study is that LiCl increased 17-OH-DHA formation in rat like lithium, have been reported to increase brain HETE concentrations (19, (42) (43) (44) (45) .
In this study, high dose LPS infusion also increased brain AA and PGE 2 concentrations and cPLA 2 -IV and sPLA 2 activities, without changing the brain DHA concentration or iPLA 2 -VI activity, consistent with evidence that iPLA 2 -VI is selective for DHA hydrolysis from phospholipid (25). Although the high dose LPS significantly increased both cPLA 2 -IV and sPLA 2 activities more than did the low dose, we did not observe a dose-dependent response to LPS in the brain unesterified AA concentration.
These data suggest that AA, released by cPLA 2 and sPLA 2 during high dose LPS infusion, was converted rapidly to eicosanoids and/or reincorporated into brain phospholipids (46, 47) . Pretreatment with the LiCl diet prevented only the effect on sPLA 2 activity.
The results from this study are consistent with our ischemia study and other In our previous study using another rodent diet we could not detect PGE 2 in control microwaved brain (without a cannula) (27). Additionally, we showed that intracerebrallyinjected d 4 -PGE 2 was not degraded substantially by the microwaving procedure (27).
These observations indicate that little endogenous PGE 2 is produced in the absence of a brain insult, and that the PGE 2 that we could detect in the two brains in this study likely was associated with cannula-related damage (35). In contrast to our earlier report regarding ischemia (27), we did not detect E 2 /D 2 isoprostanes in any sample. TXB 2 also This study also investigated possible effects of cannula implantation followed by a 6-day aCSF infusion. Except for a change in PGE 2 , the procedure did not affect any Table 2 Effects of 6-day LPS infusion and 6-week LiCl diet on concentrations of unesterified fatty acids, HETEs and 17-OH-DHA in rat brains 
